Nanobiotix ( (NBTX) ) just unveiled an announcement.
On March 31, 2025, Nanobiotix announced it will release its financial results for the fourth quarter and full year of 2024 on April 2, 2025. This announcement will be followed by a conference call and webcast on April 3, 2025, where the company’s CEO and CFO will discuss the year-end results and provide updates on business activities. This event is significant for stakeholders as it provides insights into the company’s financial health and strategic direction.
More about Nanobiotix
Nanobiotix is a late-stage clinical biotechnology company, founded in 2003 and headquartered in Paris, France. The company is pioneering nanoparticle-based therapeutic approaches aimed at revolutionizing treatment outcomes for cancer and other major diseases. Nanobiotix is listed on Euronext Paris and the Nasdaq Global Select Market, and it owns over 25 patent families related to nanotechnology platforms with applications in oncology, bioavailability and biodistribution, and central nervous system disorders.
YTD Price Performance: 24.48%
Average Trading Volume: 14,234
Technical Sentiment Signal: Hold
Current Market Cap: $175.2M
See more insights into NBTX stock on TipRanks’ Stock Analysis page.